1.Bruni, L et al. (2017) ICO/IARC Information Centre on Papillomavirus and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report, Barcelona, Spain. (Accessed 09 May 2017).
2.National Institute of Cancer (2015) Cancer Incidence in Brazil. Estimate/2016. Rio de Janeiro: INCA.
3.Burd, EM (2003) Human papillomavirus and cervical cancer. Clinical Microbiology Reviews 16, 1–17.
4.Natphopsuk, S et al. (2012) Risk factors for cervical cancer in northeastern Thailand: detailed analyses of sexual and smoking behavior. Asian Pacific Journal of Cancer Prevention 13, 5489–5495.
5.Rocha, DA et al. (2013) High prevalence and genotypic diversity of the human papillomavirus in Amazonian women, Brazil. Infectious Diseases in Obstetrics and Gynecology 2013, 514859.
6.Bruni, L et al. (2010) Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. The Journal of Infectious Diseases 202, 1789–1799.
7.Crawford, R et al. (2011) High prevalence of HPV in non-cervical sites of women with abnormal cervical cytology. BMC Cancer 11, 473.
8.Kay, P et al. (2003) High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia. Journal of Medical Virology 71, 265–273.
9.Sargent, A et al. (2008) Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. British Journal of Cancer 98, 1704–1709.
10.Srivastava, S, Gupta, S and Roy, JK (2012) High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern Uttar Pradesh, India: a population-based study. Journal of Biosciences 37, 63–72.
11.Vaccarella, S et al. (2006) Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiology, Biomarkers & Prevention 15, 2148–2153.
12.Lowy, DR and Schiller, JT (2012) Reducing HPV-associated cancer globally. Cancer Prevention Research 5, 18–23.
13.Pomfret, TC, Gagnon, JM Jr. and Gilchrist, AT (2011) Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics. Journal of Clinical Pharmacy and Therapeutics 36, 1–9.
14.Santos Filho, MV et al. (2016) Prevalence of human papillomavirus (HPV), distribution of HPV types, and risk factors for infection in HPV-positive women. Genetics and Molecular Research 15, 1–9. doi: gmr.15028315.
15.Gontijo, RC et al. (2005) Citologia oncológica, captura de híbridos II e inspeção visual no rastreamento de lesões cervicais. Cadernos de Saúde Pública 21, 141–149.
16.Silva, TT et al. (2006) Identificação de tipos de papilomavirus e de outros fatores de risco para neoplasia intra-epitelial cervical. Revista Brasileira de Ginecologia e Obstetrícia 28, 285–291.
17.Manos, MM et al. (1989) The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cell 7, 209–214.
18.de Roda Husman, AM et al. (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. Journal of General Virology 76, 1057–1062.
19.Staden, R (1996) The Staden sequence analysis package. Molecular Biotechnology 5, 233–241.
20.Altschul, SF et al. (1990) Basic local alignment search tool. Journal of Molecular Biology 215, 403–410.
21.de Sanjosé, S et al. (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. The Lancet Infectious Diseases 7, 453–459.
22.Baldez da Silva, MF et al. (2009) HPV31 and HPV33 incidence in cervical samples from women in Recife, Brazil. Genetics and Molecular Research 8, 1437–1443.
23.Entiauspe, LG et al. (2014) High incidence of oncogenic HPV genotypes found in women from Southern Brazil. Brazilian Journal of Microbiology 45, 689–694.
24.Rabelo-Santos, SH et al. (2003) Human papillomavirus prevalence among women with cervical intraepithelial neoplasia III and invasive cervical cancer from Goiânia, Brazil. Memorias do Instituto Oswaldo Cruz 98, 181–184.
25.Lippman, SA et al. (2010) Prevalence, distribution and correlates of endocervical human papillomavirus types in Brazilian women. International Journal of STD & AIDS 21, 105–109.
26.Oliveira, LH et al. (2010) Human papillomavirus genotypes in asymptomatic young women from public schools in Rio de Janeiro, Brazil. Revista da Sociedade Brasileira de Medicina Tropical 43, 4–8.
27.Nayereh, KG and Khadem, G (2012) Preventive and therapeutic vaccines against human papillomaviruses associated cervical cancers. Iranian Journal of Basic Medical Sciences 15, 585–601.
28.Raiol, T et al. (2009) Genetic variability and phylogeny of the high-risk HPV-31, -33, -35, -52, and -58 in central Brazil. Journal of Medical Virology 81, 685–692.
29.Ribeiro, AA et al. (2011) Association between HPV types and species groups and cervical neoplasia from a high-risk area for cervical cancer, Goiânia, Brazil. International Journal of Gynecological Pathology 30, 288–294.
30.Chagas, BS et al. (2015) Association study between cervical lesions and single or multiple vaccine-target and non-vaccine target human papillomavirus (HPV) types in women from Northeastern Brazil. PLoS ONE 10, e0132570.
31.Nunes, JD et al. (2014) Molecular detection of human papillomavirus in Brazilian women with cervical intraepithelial neoplasia in a northeast Brazilian city. Genetics and Molecular Research 13, 9077–9085.
32.Fernandes, JV et al. (2011) Human papillomavirus prevalence in women with normal cytology and with cervical cancer in Natal, Brazil. Molecular Medicine Reports 4, 1321–1326.
33.Fernandes, JV et al. (2010) Prevalence of human papillomavirus in archival samples obtained from patients with cervical pre-malignant and malignant lesions from Northeast Brazil. BMC Research Notes 3, 96.
34.Oliveira, FA et al. (2012) Human papillomavirus genotype distribution and risk factors for infection in women from a small municipality in north east Brazil. International Journal of STD & AIDS 23, e5–10.
35.Batista, JE et al. (2017) Human papillomavirus genotypes 68 and 58 are the most prevalent genotypes in women from quilombo communities in the state of Maranhão, Brazil. International Journal of Infectious Diseases 55, 51–55.
36.Bruni, L et al. (2016) ICO/IARC Information Centre on Papillomavirus and Cancer (HPV Information Centre). Kenya: Human Papillomavirus and Related Cancers. Fact Sheet. (Accessed 9 June 2016).
37.Bruno, A et al. (2014) Genotype distribution of human papillomavirus in women from the state of Bahia, Brazil. Revista Brasileira de Ginecologia e Obstetrícia 36, 416–422.
38.Castellsagué, X (2008) Natural history and epidemiology of HPV infection and cervical cancer. Gynecologic Oncology 110, S4–S7.
39.Clifford, GM et al. (2003) Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. British Journal of Cancer 89, 101–105.
40.Castro, MM et al. (2011) Prevalence of human papillomavirus (HPV) type 16 variants and rare HPV types in the central Amazon region. Genetics and Molecular Research 10, 186–196.
41.Camara, GN et al. (2003) Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil. Memorias do Instituto Oswaldo Cruz 98, 879–883.
42.Andall-Brereton, GM et al. (2011) Human papillomavirus genotypes and their prevalence in a cohort of women in Trinidad. Revista Panamericana de Salud Pública 29, 220–226.
43.Nahar, Q et al. (2014) Genital human papillomavirus infection among women in Bangladesh: findings from a population-based survey. PLoS ONE 9, e107675.
44.Fernandes, JV et al. (2009) Prevalence of HPV infection by cervical cytologic status in Brazil. International Journal of Gynecology & Obstetrics 105, 21–24.
45.de Mendonça, VG et al. (2010) Human papillomavirus cervical infection: viral genotyping and risk factors for high-grade squamous intraepithelial lesion and cervix cancer. Revista Brasileira de Ginecologia e Obstetricia 32, 476–485.
46.Coser, J et al. (2013) Prevalence and genotypic diversity of cervical human papillomavirus infection among women from an urban center in Brazil. Genetics and Molecular Research 12, 4276–4285.
47.Ayres, AR and Silva, GA (2010) Cervical HPV infection in Brazil: systematic review. Revista de Saúde Pública 44, 963–974.
48.Cornall, AM et al. (2013) Anal and perianal squamous carcinomas and high-grade intraepithelial lesions exclusively associated with ‘low-risk’ HPV genotypes 6 and 11. International Journal of Cancer 133, 2253–2258.
49.Salehi-Vaziri, M et al. (2016) Distribution of human papillomavirus genotypes in Iranian women according to the severity of the cervical lesion. Iranian Red Crescent Medical Journal 18, e24458.
50.Markowitz, LE et al. (2013) Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010. The Journal of Infectious Diseases 208, 385–393.
51.Castellsagué, X et al. (2014) Prospective seroepidemiologic study on the role of Human Papillomavirus and other infections in cervical carcinogenesis: evidence from the EPIC cohort. International Journal of Cancer 135, 440–452.
52.International Collaboration of Epidemiological Studies of Cervical Cancer (2009) Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies. Cancer Epidemiology, Biomarkers & Prevention 18, 1060–1069.
53.Rosa, MI et al. (2008) Persistence and clearance of human papillomavirus infection: a prospective cohort study. American Journal of Obstetrics and Gynecology 199, 617.e1–617.e17.